An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.
Myasthenia Gravis
DRUG: tacrolimus
Improvement of clinical symptoms, 28 Weeks
Improvement of daily activity, 28 Weeks
The purpose of the study is to investigate the efficacy and safety for steroid resistant, non-thymectomized MG patients.